These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7535073

  • 1. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
    Ono M.
    Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.
    Cancer Chemother Pharmacol; 1997 Feb; 39(3):259-66. PubMed ID: 8996530
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G, Ahlin A, Dahllöf G, Elinder G, Henter JI, Palmblad J.
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [Abstract] [Full Text] [Related]

  • 6. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H, Silbermann S, Weller S, Kirschke R, Körholz D, Janssen G, Göbel U, Nürnberger W.
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE.
    Ribarska JT, Jolevska ST, Panovska AP, Dimitrovska A.
    Acta Pharm; 2008 Jun; 58(2):199-206. PubMed ID: 18515229
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T.
    AIDS; 1999 Jun; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [Abstract] [Full Text] [Related]

  • 10. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
    Takeshita A, Ohno R, Hirashima K, Toyama K, Okuma M, Saito H, Ikeda Y, Tomonaga M, Asano S.
    Rinsho Ketsueki; 1995 Jun; 36(6):606-14. PubMed ID: 7543956
    [Abstract] [Full Text] [Related]

  • 11. Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor.
    Holloway CJ.
    Eur J Cancer; 1994 Jun; 30A Suppl 3():S2-6. PubMed ID: 7535067
    [Abstract] [Full Text] [Related]

  • 12. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
    Linch DC, Scarffe H, Proctor S, Chopra R, Taylor PR, Morgenstern G, Cunningham D, Burnett AK, Cawley JC, Franklin IM.
    Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552
    [Abstract] [Full Text] [Related]

  • 13. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
    Morstyn G, Foote M, Perkins D, Vincent M.
    Stem Cells; 1994 Apr; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children.
    Donadieu J, Boutard P, Tchernia G, Oster G, Gordon-Smith EC, Philippe N, Le Gall E, Nivelon JL, Dopfer P, Babin-Boilletot A.
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):441-8. PubMed ID: 7538658
    [Abstract] [Full Text] [Related]

  • 15. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.
    Frampton JE, Yarker YE, Goa KL.
    Drugs; 1995 May; 49(5):767-93. PubMed ID: 7541335
    [Abstract] [Full Text] [Related]

  • 16. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production.
    Decleva E, Cramer R, Zabucchi G.
    Int J Tissue React; 1995 May; 17(5-6):191-8. PubMed ID: 8835629
    [Abstract] [Full Text] [Related]

  • 17. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
    Höglund M.
    Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685
    [Abstract] [Full Text] [Related]

  • 18. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome.
    Ventura A, Dragovich D, Luxardo P, Zanazzo G.
    Haematologica; 1995 Dec; 80(3):227-9. PubMed ID: 7545636
    [Abstract] [Full Text] [Related]

  • 19. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G, Mattii L, Azzarà A, Brizzi S, Galimberti S, Zucca A, Benedetti E, Petrini M.
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [Abstract] [Full Text] [Related]

  • 20. In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trial.
    Fossat C, Stoppa AM, Sainty D, Blaise D, Viens P, Bayssas M, Yver A, Juhan-Vague I, Maraninchi D.
    Stem Cells; 1994 May; 12(3):322-8. PubMed ID: 7521242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.